{"id":35698,"date":"2025-10-31T02:19:10","date_gmt":"2025-10-31T02:19:10","guid":{"rendered":"https:\/\/www.europesays.com\/lv\/35698\/"},"modified":"2025-10-31T02:19:10","modified_gmt":"2025-10-31T02:19:10","slug":"covid-19-vakcina-slepenais-ierocis-pret-vezi-petijuma-atklaj-ka-vakcinetie-iespejams-dzivo-ilgak","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/lv\/35698\/","title":{"rendered":"Covid-19 vakc\u012bna slepenais ierocis pret v\u0113zi? P\u0113t\u012bjum\u0101 atkl\u0101j, ka vakcin\u0113tie, iesp\u0113jams, dz\u012bvo ilg\u0101k\u2026"},"content":{"rendered":"

\" \"\/<\/p>\n

Publicit\u0101tes foto\n<\/p>\n

P\u0113tnieki<\/a> atkl\u0101j, ka v\u0113\u017ea slimnieki izdz\u012bvo iev\u0113rojami ilg\u0101k, ja aptuveni imunoterapijas laik\u0101 sa\u0146em mRNS vakc\u012bnu pret COVID-19. Zin\u0101tnieki nor\u0101da, ka t\u0101 darbojas k\u0101 sava veida im\u016bnsist\u0113mas pastiprin\u0101t\u0101js, padarot audz\u0113jus uz\u0146\u0113m\u012bg\u0101kus pret \u0101rst\u0113\u0161anu.<\/p>\n

Las\u012bt\u0101kie
\n <\/p>\n

\"\"<\/p>\n

Veselam<\/p>\n

\n Nekad nekombin\u0113jiet medu ar \u0161iem se\u0161iem p\u0101rtikas produktiem: l\u016bk, k\u0101p\u0113c!\n <\/p>\n

<\/a><\/p>\n

\"\"<\/p>\n

Kokteilis<\/p>\n

\u201cVisp\u0101r vajadz\u0113tu aizliegt Donu un vi\u0146a jauno dziesmu\u2026\u201d M\u016bzi\u0137a jaun\u0101kais veikums izraisa negaid\u012btu sabiedr\u012bbas reakciju<\/p>\n

<\/a><\/p>\n

\"\"<\/p>\n

\n \u201cNevien\u0101 no ierakstiem, nevien\u0101 ska\u0146u celi\u0146\u0101\u2026\u201d Dienesta p\u0101rbaud\u0113 saist\u012bb\u0101 ar su\u0146u no\u0161au\u0161anu atkl\u0101ti smagi p\u0101rk\u0101pumi<\/p>\n

<\/a>
\n Las\u012bt citas zi\u0146as<\/a><\/p>\n

COVID-19 vakc\u012bna s\u0101kotn\u0113ji bija paredz\u0113ta aizsardz\u012bbai pret v\u012brusu, nevis v\u0113zi. Ta\u010du da\u017eos gad\u012bjumos \u0161\u0137iet, ka t\u0101 pal\u012bdz ar\u012b c\u012b\u0146\u0101 ar audz\u0113jiem. Jauns v\u0113\u017ea centra p\u0113t\u012bjums atkl\u0101j, ka pacienti ar \u0101das vai plau\u0161u v\u0113zi dz\u012bvoja iev\u0113rojami ilg\u0101k, ja vi\u0146i sa\u0146\u0113ma mRNS vakc\u012bnu, \u012bpa\u0161i laik\u0101, kad s\u0101kta imunoterapija.<\/p>\n

Vid\u0113ji vakcin\u0113tie pacienti ar nes\u012bk\u0161\u016bnu plau\u0161u v\u0113zi izdz\u012bvoja gandr\u012bz 37 m\u0113ne\u0161us, kam\u0113r nevakcin\u0113tie \u2013 aptuveni 21 m\u0113nesi. Metast\u0101tiskas melanomas gad\u012bjum\u0101 tr\u012bs gadu izdz\u012bvo\u0161anas r\u0101d\u012bt\u0101js bija 67%, sal\u012bdzinot ar 44% nevakcin\u0113tiem pacientiem.<\/p>\n

CITI \u0160OBR\u012aD LASA<\/p>\n

Efekts tika nov\u0113rots tikai mRNS vakc\u012bn\u0101m \u2013 konkr\u0113ti t\u0101m, ko ra\u017eo BioNTech\/Pfizer un Moderna. Tradicion\u0101l\u0101s vakc\u012bnas, piem\u0113ram, gripas vai pneimokoku, neietekm\u0113ja slim\u012bbas gaitu.<\/p>\n

K\u0101 vakc\u012bna aktiviz\u0113 im\u016bnsist\u0113mu c\u012b\u0146\u0101 ar v\u0113zi?<\/p>\n

Onkologa Adama Gripina p\u0113tnieki atkl\u0101ja, ka mRNS vakc\u012bna izraisa \u012bslaic\u012bgu, bet \u013coti sp\u0113c\u012bgu im\u016bno reakciju. 24 stundu laik\u0101 organisms izdala lielu daudzumu I tipa interferona \u2013 sign\u0101lmolekulas, kas parasti par\u0101d\u0101s v\u012brusu infekciju laik\u0101. \u0160is sign\u0101ls darbojas k\u0101 modin\u0101t\u0101ja zvans im\u016bn\u0161\u016bn\u0101m.<\/p>\n

\u201cCovid-19 vakc\u012bna darbojas k\u0101 sir\u0113na, aktiviz\u0113jot im\u016bnsist\u0113mu vis\u0101 organism\u0101,\u201d skaidro Gripins. \u201cT\u0101 pat s\u0101k programm\u0113t audz\u0113ja reakciju, kas uzbr\u016bk v\u0113zim.\u201d<\/p>\n

\u0160\u012b negaid\u012bt\u0101 blakuspar\u0101d\u012bba izr\u0101d\u012bjusies \u012bpa\u0161i noder\u012bga pacientiem, kuru audz\u0113jus im\u016bnsist\u0113ma parasti neatpaz\u012bst. Vakcin\u0101cija maina audz\u0113ja vidi \u2013 t\u0101 piesaista im\u016bn\u0101s \u0161\u016bnas, liek v\u0113\u017ea \u0161\u016bn\u0101m \u201cizn\u0101kt no sl\u0113p\u0146a\u201d un padara imunoterapiju iev\u0113rojami efekt\u012bv\u0101ku.<\/p>\n

Kad vakcin\u0101cija sniedz vislab\u0101ko efektu<\/p>\n

Efekts bija visizteikt\u0101kais, ja vakcin\u0101cija notika 100 dienu laik\u0101 pirms vai p\u0113c imunoterapijas s\u0101kuma. \u0160aj\u0101 period\u0101 kombin\u0101cija bija visefekt\u012bv\u0101k\u0101: plau\u0161u v\u0113\u017ea pacientiem dz\u012bvildze palielin\u0101j\u0101s no 20,6 l\u012bdz 37,3 m\u0113ne\u0161iem, melanomas gad\u012bjum\u0101 tr\u012bs gadu izdz\u012bvo\u0161anas r\u0101d\u012bt\u0101js pieauga no 44,1 l\u012bdz 67,6 procentiem.<\/p>\n

Papildu gripas vai pneimokoku vakc\u012bnas nel\u012bdz\u0113ja, un pacientiem, kas sa\u0146\u0113ma tikai \u0137\u012bmijterapiju bez imunoterapijas, uzlabojumu nebija. Tas liecina, ka mRNS vakc\u012bnai ir unik\u0101la iedarb\u012bba, kas savienojas tie\u0161i ar imunoterapiju.<\/p>\n

T\u0113mas<\/p>\n

SAIST\u012aTIE RAKSTI<\/p>\n","protected":false},"excerpt":{"rendered":"Publicit\u0101tes foto P\u0113tnieki atkl\u0101j, ka v\u0113\u017ea slimnieki izdz\u012bvo iev\u0113rojami ilg\u0101k, ja aptuveni imunoterapijas laik\u0101 sa\u0146em mRNS vakc\u012bnu pret…\n","protected":false},"author":2,"featured_media":35699,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[23,28,29,32,33,22,30,31,35,39,38,36,37,34,40,20,26,27,24,25,21],"class_list":{"0":"post-35698","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-aktualitates","8":"tag-aktualitates","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-featured-news","12":"tag-featurednews","13":"tag-headlines","14":"tag-latest-news","15":"tag-latestnews","16":"tag-latvia","17":"tag-latvian","18":"tag-latviesu","19":"tag-latviesu-valoda","20":"tag-latviesuvaloda","21":"tag-latvija","22":"tag-lv","23":"tag-news","24":"tag-popularakas-zinas","25":"tag-popularakaszinas","26":"tag-top-stories","27":"tag-topstories","28":"tag-zinas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115466388418256635","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/35698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=35698"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/35698\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/35699"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=35698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=35698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=35698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}